Description
Buy GHRP-6 and CJC1295 DAC Pre Mixed Blend 2.5mg
This product is intended for research purposes only. To be used by trained professionals only.
The GHRP-6 and CJC-1295 DAC Pre Mixed Blend (2.5mg) is an advanced formulation that combines two highly effective peptides for optimal growth hormone release and anabolic support. GHRP-6 is a growth hormone-releasing peptide that targets the pituitary gland, stimulating the body’s natural production of growth hormone. This action is critical for promoting muscle growth, aiding fat loss, and enhancing recovery.
When paired with CJC-1295 DAC, which offers a prolonged action through its affinity for serum proteins, the blend achieves synergistic effects that enhance both muscle development and metabolic efficiency. The pre-mixed format facilitates precise dosing and simplifies administration, further encouraging compliance in research settings.
This combination is particularly valuable for studies aiming to investigate enhancements in athletic performance, overall health, and recovery methodologies. The blend’s balanced approach allows researchers to explore the compounded benefits of its components, contributing significantly to the fields of sports science and anti-aging research.
For detailed insights into the individual peptides, including their mechanisms of action, advantages, potential side effects, and the products available from Direct Peptides Europe, please explore the main category pages.
Key Features of GHRP-6 and CJC1295 DAC Pre Mixed Blend (2.5mg)
- Optimised Peptide Combination: Blends the potent effects of GHRP-6 and CJC-1295 DAC for optimal results in growth hormone release.
- Enhanced Muscle Growth: Supports significant increases in muscle mass through powerful anabolic action.
- Accelerated Fat Loss: Promotes fat reduction while preserving lean muscle mass, contributing to an improved body composition.
- Improved Cardiac Function: May contribute to enhanced cardiovascular health by supporting endothelial function and increasing the availability of growth hormone, which can positively influence heart tissue regeneration and overall cardiac performance.
- Appetite Stimulation: Enhances appetite alongside its muscle-building and fat-loss benefits, making it beneficial for individuals looking to increase caloric intake during training or recovery phases.
- Positive Impact on CNS: The blend may support central nervous system (CNS) function, potentially enhancing cognitive performance and promoting recovery from exercise-related stress by increasing growth hormone levels which are known to influence neurogenesis and overall brain health.
- Improved Recovery Function: Facilitates faster recovery from strenuous physical activities and injury, enhancing overall performance.
- Convenient Pre Mixed Format: Simplifies the dosing and administration process, ensuring precise daily intake and consistency in research protocols.
- Synergistic Effects: Maximises the benefits of growth hormone release by concurrently utilizing GHRP-6 and CJC-1295 DAC.
- Targeted for Research Applications: Particularly well-suited for investigations in sports science, metabolic health, and anti-aging studies.
Shop the full range of pre-mixed peptide pens available from Direct Peptides Europe for premium quality research grade peptides with convenience for reconstitution.
Shipping and Handling
The GHRP-6 and CJC1295 DAC Pre Mixed Blend (2.5mg) is shipped using secure, temperature-controlled methods to ensure that the product remains stable and retains its efficacy throughout the delivery process.
Storage
To maintain the integrity and efficacy of the GHRP-6 and CJC-1295 DAC Pre Mixed Blend (2.5mg), it should be stored at a controlled temperature between 2°C and 8°C, away from direct sunlight and extreme conditions.
Discover Direct Peptides Europe complete range of peptide supplies available for research here.
References:
[1] M Granado, C García-Cáceres, L M Frago, J Argente, and J A Chowen (2010) The Positive Effects of Growth Hormone-Releasing Peptide-6 on Weight Gain and Fat Mass Accrual Depend on the Insulin/Glucose Status – Endocrinology, Volume 151, Issue 5, 1 May 2010, Pages 2008–2018.
[2] M Alba, D Fintini, A Sagazio, B Lawrence, JP Castaigne, L A Frohman, R Salvatori (2006) Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse – American Journal of Physiology. Endocrinology and Metabolism, 2006 Dec, Volume 291 (Issue 6), Pages E1290-4.
[3] A V Schally, X Zhang, R Cai, J M Hare, R Granata, and M Bartoli (2019) Actions and Potential Therapeutic Applications of Growth Hormone–Releasing Hormone Agonists – Endocrinology, Volume 160, Issue 7, July 2019, Pages 1600–1612.
ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.
DISCLAIMER: These products are intended solely as a research chemical only. This classification allows for their use only for research development and laboratory studies. The information available on our Europe Direct Peptides website: https://europe.direct-peptides.com is provided for educational purposes only. These products are not for human or animal use or consumption in any manner. Handling of these products should be limited to suitably qualified professionals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.
BUY GHRP-6 and CJC1295 DAC Pre Mixed Blend Peptide ONLINE today From Europe Direct Peptides